Literature DB >> 9872335

The LMO1 and LDB1 proteins interact in human T cell acute leukaemia with the chromosomal translocation t(11;14)(p15;q11).

V Valge-Archer1, A Forster, T H Rabbitts.   

Abstract

The ectopic expression of LMO1 or LMO2 in T cell acute leukaemias resulting from chromosomal translocations t(11;14)(p15;qll) or t(11;14)(p13;q11) respectively in a causal factor in tumorigenesis. LMO1 has been found as a heterodimer with a 46 Kd protein in a T cell line derived from a childhood T-acute leukaemia. This 46 Kd protein is the LIM-binding protein LDB1/NLI. The latter is a phosphoprotein and binds to LMO1 in its phosphorylated state and essentially all the LMO1 and LDB1 protein in the T cell line is part of the complex. Therefore, the LMO1-LDB1 interaction is likely to be involved in tumorigenesis after LMO1 is ectopically expressed following chromosomal translocation in T cells prior to development of acute leukaemias.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9872335     DOI: 10.1038/sj.onc.1202353

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

Review 1.  LIM-domain-only proteins: multifunctional nuclear transcription coregulators that interacts with diverse proteins.

Authors:  Meixiang Sang; Li Ma; Meijie Sang; Xinliang Zhou; Wei Gao; Cuizhi Geng
Journal:  Mol Biol Rep       Date:  2013-12-31       Impact factor: 2.316

2.  Single-stranded DNA-binding proteins regulate the abundance of LIM domain and LIM domain-binding proteins.

Authors:  Zhixiong Xu; Xianzhang Meng; Ying Cai; Hong Liang; Lalitha Nagarajan; Stephen J Brandt
Journal:  Genes Dev       Date:  2007-04-15       Impact factor: 11.361

3.  Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair.

Authors:  Myriam Alcalay; Natalia Meani; Vania Gelmetti; Anna Fantozzi; Marta Fagioli; Annette Orleth; Daniela Riganelli; Carla Sebastiani; Enrico Cappelli; Cristina Casciari; Maria Teresa Sciurpi; Angela Rosa Mariano; Simone Paolo Minardi; Lucilla Luzi; Heiko Muller; Pier Paolo Di Fiore; Guido Frosina; Pier Giuseppe Pelicci
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

4.  Tandem LIM domains provide synergistic binding in the LMO4:Ldb1 complex.

Authors:  Janet E Deane; Daniel P Ryan; Margaret Sunde; Megan J Maher; J Mitchell Guss; Jane E Visvader; Jacqueline M Matthews
Journal:  EMBO J       Date:  2004-09-02       Impact factor: 11.598

5.  Ldb1 is required for Lmo2 oncogene-induced thymocyte self-renewal and T-cell acute lymphoblastic leukemia.

Authors:  LiQi Li; Apratim Mitra; Kairong Cui; Bin Zhao; Seeyoung Choi; Jan Y Lee; Daniel B Stamos; Dalal El-Khoury; Claude Warzecha; Karl Pfeifer; Joyce Hardwick; Keji Zhao; Bryan Venters; Utpal P Davé; Paul E Love
Journal:  Blood       Date:  2020-06-18       Impact factor: 22.113

6.  Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice.

Authors:  E Tse; A J H Smith; S Hunt; I Lavenir; A Forster; A J Warren; G Grutz; L Foroni; M B L Carlton; W H Colledge; T Boehm; T H Rabbitts
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

Review 7.  LIM-domain-binding protein 1: a multifunctional cofactor that interacts with diverse proteins.

Authors:  Jacqueline M Matthews; Jane E Visvader
Journal:  EMBO Rep       Date:  2003-12       Impact factor: 8.807

Review 8.  Transcriptional regulation of haematopoietic transcription factors.

Authors:  Nicola K Wilson; Fernando J Calero-Nieto; Rita Ferreira; Berthold Göttgens
Journal:  Stem Cell Res Ther       Date:  2011-02-10       Impact factor: 6.832

9.  The LMO2 -25 Region Harbours GATA2-Dependent Myeloid Enhancer and RUNX-Dependent T-Lymphoid Repressor Activity.

Authors:  Nicolas Bonadies; Berthold Göttgens; Fernando J Calero-Nieto
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

10.  Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia.

Authors:  S H Oram; J Thoms; J I Sive; F J Calero-Nieto; S J Kinston; J Schütte; K Knezevic; R B Lock; J E Pimanda; B Göttgens
Journal:  Leukemia       Date:  2013-01-10       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.